Hexagon Bio
CA - Menlo ParkBiotechnology
Focus: Hexagon Bio is a pre-revenue biotech company focused on fungal genomic sequencing with potential therapeutic applications in oncology. The company is based in Menlo Park, CA and operates at an early stage with minimal clinical development activity.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Hexagon Bio?
AI assessmentHexagon Bio is a high-risk, high-discovery-potential early-stage play best suited for scientists seeking foundational-science roles and tolerance for uncertainty.
Why Work Here
- Early-stage scientific opportunity in an emerging modality (fungal genomics) with oncology applications and published research foundation (5 publications).
- Strategic partnership with Corteva announced in late 2024 signals external validation and potential for multi-million dollar collaboration.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Hexagon Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.